News | February 24, 2026
Sai Life Sciences to hire 700+ as Indian CRDMO sector surges
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
Subscribe To Our Newsletter & Stay Updated
